A class of human exons with predicted distant branch points revealed by analysis of AG dinucleotide exclusion zones

被引:86
作者
Gooding, C
Clark, F
Wollerton, MC
Grellscheid, SN
Groom, H
Smith, CWJ
机构
[1] Univ Cambridge, Dept Biochem, Cambridge CB2 1GA, England
[2] Univ Queensland, Adv Computat Modelling Ctr, St Lucia, Qld 4067, Australia
[3] Univ Queensland, ARC Ctr Bioinformat, St Lucia, Qld 4067, Australia
基金
英国惠康基金;
关键词
D O I
10.1186/gb-2006-7-1-r1
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Background: The three consensus elements at the 3' end of human introns-the branch point sequence, the polypyrimidine tract, and the 3' splice site AG dinucleotide-are usually closely spaced within the final 40 nucleotides of the intron. However, the branch point sequence and polypyrimidine tract of a few known alternatively spliced exons lie up to 400 nucleotides upstream of the 3' splice site. The extended regions between the distant branch points (dBPs) and their 3' splice site are marked by the absence of other AG dinucleotides. In many cases alternative splicing regulatory elements are located within this region. Results: We have applied a simple algorithm, based on AG dinucleotide exclusion zones (AGEZ), to a large data set of verified human exons. We found a substantial number of exons with large AGEZs, which represent candidate dBP exons. We verified the importance of the predicted dBPs for splicing of some of these exons. This group of exons exhibits a higher than average prevalence of observed alternative splicing, and many of the exons are in genes with some human disease association. Conclusion: The group of identified probable dBP exons are interesting first because they are likely to be alternatively spliced. Second, they are expected to be vulnerable to mutations within the entire extended AGEZ. Disruption of splicing of such exons, for example by mutations that lead to insertion of a new AG dinucleotide between the dBP and 3' splice site, could be readily understood even though the causative mutation might be remote from the conventional locations of splice site sequences.
引用
收藏
页数:19
相关论文
共 57 条
[1]   Mechanisms of alternative pre-messenger RNA splicing [J].
Black, DL .
ANNUAL REVIEW OF BIOCHEMISTRY, 2003, 72 :291-336
[2]   Exonic splicing enhancers: mechanism of action, diversity and role in human genetic diseases [J].
Blencowe, BJ .
TRENDS IN BIOCHEMICAL SCIENCES, 2000, 25 (03) :106-110
[3]  
Burge CB, 1999, RNA WORLD, P525
[4]   Alternative splicing:: multiple control mechanisms and involvement in human disease [J].
Cáceres, JF ;
Kornblihtt, AR .
TRENDS IN GENETICS, 2002, 18 (04) :186-193
[5]   Listening to silence and understanding nonsense: Exonic mutations that affect splicing [J].
Cartegni, L ;
Chew, SL ;
Krainer, AR .
NATURE REVIEWS GENETICS, 2002, 3 (04) :285-298
[6]   An upstream AG determines whether a downstream AG is selected during catalytic step II of splicing [J].
Chua, K ;
Reed, R .
MOLECULAR AND CELLULAR BIOLOGY, 2001, 21 (05) :1509-1514
[7]   Categorization and characterization of transcript-confirmed constitutively and alternatively spliced introns and exons from human [J].
Clark, F ;
Thanaraj, TA .
HUMAN MOLECULAR GENETICS, 2002, 11 (04) :451-464
[8]   Identification of a new class of exonic splicing enhancers by in vivo selection [J].
Coulter, LR ;
Landree, MA ;
Cooper, TA .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2143-2150
[9]   Predictive identification of exonic splicing enhancers in human genes [J].
Fairbrother, WG ;
Yeh, RF ;
Sharp, PA ;
Burge, CB .
SCIENCE, 2002, 297 (5583) :1007-1013
[10]   Pre-mRNA splicing and human disease [J].
Faustino, NA ;
Cooper, TA .
GENES & DEVELOPMENT, 2003, 17 (04) :419-437